New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ResMed Inc.
RMD
Shape
US Flag

NYSE

38B

Medical - Instruments & Supplies

Next Earning date - 22 Jan 2025

38B

Medical - Instruments & Supplies

Next Earning date - 22 Jan 2025

256.07USD
Shape17.02 ( 7.12%)
favorite-chart

Relative Strenght

72
favorite-chart

Volume Buzz

184%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 27, 2024
1W 6.67 % 1M 4.90 % 3M 23.09 % 1Y 88.23 %

Key Metrics

Shape
  • Market Cap

    37.58B


  • Shares Outstanding

    146.77M


  • Share in Float

    145.60M


  • Dividende

    2.12


  • Earning Date

    22 Jan 2025


  • Price Target

    256.07


  • Average Volume

    1.01M


  • Beta

    0.689


  • Range

    132.24-260.49


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.resmed.com


  • Sector

    Healthcare


Fundamentals

Shape

30.89x

P/E Ratio

7.82x

P/S Ratio

7.24x

P/B Ratio

0.2

Debt/Equity

23.1%

Net Margin

$7.5

EPS

How RMD compares to sector?

P/E Ratio

Relative Strength

Shape

RMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape318%

2025-Revenue

$9.01

Shape325%

2025-EPS

$2B

Shape342%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wolfe Research

downgrade

Previous: Peer Perform

2024-09-18

Now: Underperform

Needham

downgrade

Previous: Buy

2024-09-04

Now: Hold

Oppenheimer

downgrade

Previous: Outperform

2024-06-25

Now: Perform

Morgan Stanley

upgrade

Previous: Equal-Weight

2023-10-27

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+13%

1.66
vs 1.47

Q1.23

arrow
arrow

+27%

1.68
vs 1.32

Q2.23

arrow
arrow

+7%

1.6
vs 1.49

Q3.23

arrow
arrow

+9%

1.64
vs 1.51

Q4.23

arrow
arrow

+13%

1.88
vs 1.66

Q1.24

arrow
arrow

+27%

2.13
vs 1.68

Q2.24

arrow
arrow

+30%

2.08
vs 1.6

Q3.24

arrow
arrow

+34%

2.2
vs 1.64

Q4.24

arrow
arrow

+23%

2.31
vs 1.88

Q1.25

arrow
arrow

+12%

2.39
vs 2.13

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+16%

1B  vs 894.9M

Q1.23

arrow
arrow

+29%

1.1B  vs 864.5M

Q2.23

arrow
arrow

+23%

1.1B  vs 914.7M

Q3.23

arrow
arrow

+1%

963M  vs 950.3M

Q4.23

arrow
arrow

+12%

1.2B  vs 1B

Q1.24

arrow
arrow

+7%

1.2B  vs 1.1B

Q2.24

arrow
arrow

+9%

1.2B  vs 1.1B

Q3.24

arrow
arrow

+27%

1.2B  vs 963M

Q4.24

arrow
arrow

+9%

1.3B  vs 1.2B

Q1.25

arrow
arrow

+8%

1.3B  vs 1.2B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+6%

0.06
vs 0.06

Q1.23

arrow
arrow

+6%

0.06
vs 0.06

Q2.23

arrow
arrow

+6%

0.06
vs 0.06

Q3.23

arrow
arrow

+5%

0.05
vs 0.06

Q4.23

arrow
arrow

+5%

0.05
vs 0.05

Q1.24

arrow
arrow

+6%

0.06
vs 0.05

Q2.24

arrow
arrow

+6%

0.06
vs 0.06

Q3.24

arrow
arrow

+6%

0.06
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

673

673
vs 677

-1%

Q4.22

arrow
arrow

732

732
vs 673

9%

Q1.23

arrow
arrow

680

680
vs 732

-7%

Q2.23

arrow
arrow

740

740
vs 680

9%

Q3.23

arrow
arrow

682

682
vs 740

-8%

Q4.23

arrow
arrow

712

712
vs 682

4%

Q1.24

arrow
arrow

745

745
vs 712

5%

Q2.24

arrow
arrow

785

785
vs 745

5%

Earnings Growth

Latest News